Female Representation in Clinical Trials

Female representation in clinical trials refers to including women equally with men in medical research to ensure treatments are safe and effective for everyone. Historically, women have been underrepresented, which can lead to gaps in understanding how drugs or therapies affect women differently. Accurate female representation helps identify sex-specific responses, improves health outcomes, and ensures medical care is based on comprehensive data. Ensuring balanced participation promotes equitable healthcare and supports the development of treatments that work effectively for all genders.